FDA Approves IL-15 Receptor Agonist for BCG-Unresponsive NMIBC | GU Oncology Now
The FDA approved Anktiva for patients with BCG-unresponsive NMIBC with CIS with or without papillary tumors.
The FDA approved Anktiva for patients with BCG-unresponsive NMIBC with CIS with or without papillary tumors.
Men taking a common medication for hair loss should be aware of potentially serious psychiatric and sexual side effects including insomnia (sleeplessness).
Investors and commentators slammed Hims & Hers CEO Andrew Dudum on social media after he extended job offers to anti-Israel college students protesting on campus.
In this randomized controlled experimental study, a brief provocation of anger adversely affected endothelial cell health by impairing endothelium‐dependent v
BackgroundCopper exposure is reported to be associated with increased risk of stroke. However, the association of copper exposure with subclinical carotid atherosclerosis remains unclear.Methods an…
Find news and updates from the 49th Annual Oncology Nursing Society (ONS) Congress, which features presentations, sessions, networking opportunities, and exhibits.
Hosted by Chadi Nabhan, MD, the inaugural HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 3-4 in Chicago.
Read in-depth coverage of the AUA 2024 Annual Meeting, featuring the latest research and science on urology from GU oncology experts and key opinion leaders.
Hosted by Chadi Nabhan, MD, the inaugural HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 3-4 in Chicago.
Read in-depth coverage of the AUA 2024 Annual Meeting, featuring the latest research and science on urology from GU oncology experts and key opinion leaders.
Researchers are reporting that menopause hormone replacement therapy may not actually reduce the risk of heart disease. They add that calcium and vitamin D supplements…